Endothelial Function, Arterial Stiffness and Components
NCT01439217 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32
Last updated 2013-04-17
Summary
Specific Aim: Compare the endothelial function, arterial stiffness and components of metabolic syndrome of childhood Acute Lymphoblastic Leukemia (ALL) survivors to healthy sibling controls. Plan: A cross sectional study comparing ALL survivors to sibling controls including measures of endothelial function and arterial stiffness obtained form a peripheral artery tonometry device, height, weight, waist circumference, fasting lipid, glucose and insulin.
Conditions
Sponsors & Collaborators
-
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
lead OTHER
Eligibility
- Min Age
- 8 Years
- Max Age
- 28 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-06-30
- Primary Completion
- 2013-02-28
- Completion
- 2013-02-28
Countries
- United States
Study Locations
More Related Trials
-
Combination Chemotherapy and Dasatinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
NCT01238211 ·Status: COMPLETED ·Phase: PHASE2
-
EPIgenetics and in Vivo Resistance of Chronic Myeloid Leukemia Stem Cells to Tyrosine Kinase Inhibitors
NCT03481868 ·Status: RECRUITING ·Phase: NA
-
Consolidation Therapy for Acute Myeloid Leukemia Guided by Leukemia Stem Cell Behavior
NCT01588951 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Biomarkers in Predicting Response to Treatment in Bone Marrow Samples From Young Patients With Acute Myeloid Leukemia
NCT01321385 ·Status: COMPLETED
-
Diagnostic Study of Gene Alterations in Patients With Acute Myeloid Leukemia
NCT00003931 ·Status: COMPLETED
-
Collection of Blood and Bone Marrow Samples From Select Patients With CML to Measure Minimal Residual Disease
NCT00819143 ·Status: COMPLETED
-
Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT00720109 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Chronic Myelod Leukemia Registry at Asan Medical Center
NCT01761695 ·Status: TERMINATED
-
Studying Samples From Patients With T-Cell Acute Lymphoblastic Leukemia
NCT01581528 ·Status: COMPLETED
-
Phase II Study of Azacitidine and Sargramostim as Maintenance Treatment for Poor-Risk AML or MDS
NCT01700673 ·Status: COMPLETED ·Phase: PHASE2
-
Detection of Residual Disease in Children Receiving Therapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome
NCT00003790 ·Status: COMPLETED
-
Transfusion in Adult Acute Myeloid Leukemia
NCT02899767 ·Status: COMPLETED
-
Dasatinib in Combination With Chemotherapy for Relapsed or Refractory Core Binding Factor Acute Myeloid Leukemia
NCT02680951 ·Status: WITHDRAWN ·Phase: PHASE1
-
Investigating the Relationship Between Physical Function, Comorbidity and Cytogenetic Risk Group in Older Adults With Acute Myelogenous Leukemia (AML)
NCT02662933 ·Status: COMPLETED ·Phase: NA
-
Reduced Intensity Conditioning Transplantation Versus Standard of Care in Acute Myeloid Leukemia
NCT00342316 ·Status: COMPLETED ·Phase: NA
-
A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Adult ALL
NCT06557161 ·Status: RECRUITING ·Phase: PHASE2
-
Acute Myeloid Leukemia At Initial Diagnosis and/or Relapse in Children, Teenagers and Young Adults: Molecular Profiling, Multidrug Testing and MSC Interaction Studies
NCT05772559 ·Status: RECRUITING
-
Identifying Cancer Genes in in Blood and Bone Marrow Samples From Patients With Acute Myeloid Leukemia
NCT00897182 ·Status: COMPLETED
-
Interest of PHARMaceutical Conciliation to Understand Drug Interactions, Phytotherapy, and Targeted Therapies in Chronic Myeloid Leukemia
NCT05130138 ·Status: RECRUITING ·Phase: NA
-
Transfusion Dependency at Diagnosis and Transfusion Intensity During Initial Chemotherapy Are Associated With Poorer Outcomes in Adult Acute Myeloid Leukaemia
NCT02844257 ·Status: COMPLETED
-
Prospective Study on Severe Infections on Acute Myeloid Leukemia (AML) Patients
NCT01570465 ·Status: TERMINATED
-
Immunophenotyping of Blood Cells in the Diagnosis Work-up of Myelodysplastic Syndromes
NCT03621241 ·Status: RECRUITING
-
Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases
NCT05800210 ·Status: RECRUITING ·Phase: PHASE2
-
Pharmacoeconomics in the Application of 5-azacitidine in the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia
NCT04296214 ·Status: WITHDRAWN
-
Outcomes of Acute Myeloid Leukemia Patients
NCT04392310 ·Status: UNKNOWN